Hormone replacement therapy after treatment for a gynaecological malignancy.

@article{ODonnell2016HormoneRT,
  title={Hormone replacement therapy after treatment for a gynaecological malignancy.},
  author={Rachel Louise O'Donnell and Katherine M Clement and Richard J Edmondson},
  journal={Current opinion in obstetrics & gynecology},
  year={2016},
  volume={28 1},
  pages={32-41}
}
PURPOSE OF REVIEW Provision of hormone replacement therapy (HRT) to women following a diagnosis of a gynaecological malignancy is a complex and controversial area associated with a lack of published guidance. As the average age of women affected by gynaecological cancer decreases and survival following provision of effective therapies increases, clinicians face new considerations for longer-term health concerns of patients. Additionally, there is a growing understanding of the influence of… CONTINUE READING